メチルフェニデートはドーパミン作動性調節を介して皮質階層を再編成する
Dardo Tomasi1, Peter Manza2,3, Şükrü Barış Demiral2
1National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA. dardo.tomasi@nih.gov.
Nature communications
|December 13, 2025
まとめ
メチルフェニデート(MP)は脳の機能的階層を圧縮し、神経伝達を変化させます。このドーパミン駆動型の再編成は、注意力の向上と受容体の利用可能性における個人差に関連しています。
科学分野:
- 神経科学
- 認知神経科学
- 神経画像
背景:
- ドーパミン作動性シグナル伝達は、センサー運動から連合皮質への勾配に沿って脳ネットワークのアーキテクチャに影響を与えます。
- メチルフェニデート(MP)のようなドーパミン増強性精神刺激薬がこの機能的階層と注意に及ぼす影響は不明なままです。
研究 の 目的:
- メチルフェニデート(MP)がヒト脳の主要な機能勾配にどのように影響するかを調査すること。
- MPによって誘発された皮質組織の変化が注意およびドーパミン受容体の利用可能性に関連するかどうかを判断すること。
主な方法:
- MP投与後のPETおよびfMRIを使用した健康な成人(n=38、n=20)を対象とした2つの二重盲検、プラセボ対照研究。
- 青少年脳認知発達(ABCD)研究(n=4,958)からの大規模な独立したコホートでの検証。
主要な成果:
- メチルフェニデート(MP)は、感覚皮質と連合皮質間の分離を減らし、主要な機能勾配を一貫して圧縮しました。
- 勾配圧縮の程度は、個人ごとの線条体D1およびD2受容体の利用可能性と相関していました。
- MPによって誘発された下頭頂皮質における勾配圧縮は、注意力の向上と関連していました。
結論:
- ドーパミン感受性メカニズムは、認知パフォーマンスをサポートする皮質機能再編成の根底にあります。
- メチルフェニデート(MP)は、大規模な脳ネットワーク組織を変化させ、勾配圧縮メカニズムを介して注意に影響を与えます。
関連する概念動画
Adrenergic Agonists: Indirect-Acting Agents
2.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.5K
Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K
Attention-Deficit/Hyperactivity Disorder
709
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
709
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
724
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
724
Drugs Affecting Neurotransmitter Release or Uptake
1.5K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.5K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.8K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.8K


